Pentagastrin
NDC Package 51808-207-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Pentagastrin is anacidity (diagnosis)—Pentagastrin is indicated as a diagnostic aid for evaluation of gastric acid secretory function. Marketed by Anazaohealth Corporation, this product is identified by NDC 51808-207.

Identification & Billing

NDC Package Code
51808-207-01
Package Description
5 mL in 1 VIAL
Product Code
51808-207
11-Digit Billing Format
51808020701

Clinical Specifications

Proprietary Name
Pentagastrin
Dosage Form
-
Usage Information
Anacidity (diagnosis)—Pentagastrin is indicated as a diagnostic aid for evaluation of gastric acid secretory function. It is effective in testing for anacidity (achlorhydria) in patients with suspected pernicious anemia, atrophic gastritis, or gastric carcinoma. It is also effective in determining the reduction in acid output after operations for peptic ulcer, such as vagotomy or gastric resection.Hypersecretory conditions, gastric (diagnosis)—Pentagastrin is indicated as a diagnostic aid in testing for gastric hypersecretion in patients with suspected duodenal ulcer or postoperative stomal ulcer, and for the diagnosis of Zollinger-Ellison tumor

Regulatory & Marketing

Labeler Name
Anazaohealth Corporation
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
06-19-2012
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51808-207-01 identifies a specific commercial package of 5 ml in 1 vial of Pentagastrin, labeled by Anazaohealth Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Anazaohealth Corporation on June 19, 2012. The current certification is valid through December 31, 2017.

How is this Anazaohealth Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51808020701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51808-207-01
11-Digit CMS (5-4-2)
51808-0207-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.